Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model. 2021

Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
Department of Medicine, Division of Hospital Medicine, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: jshwoo@gmail.com.

Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments. Can we develop and validate a web-based risk prediction model for identification of patients who may develop severe COVID-19, defined as intensive care unit (ICU) admission, mechanical ventilation, and/or death? This retrospective cohort study reviewed 415 patients admitted to a large urban academic medical center and community hospitals. Covariates included demographic, clinical, and laboratory data. The independent association of predictors with severe COVID-19 was determined using multivariable logistic regression. A derivation cohort (n=311, 75%) was used to develop the prediction models. The models were tested by a validation cohort (n=104, 25%). The median age was 66 years (Interquartile range [IQR] 54-77) and the majority were male (55%) and non-White (65.8%). The 14-day severe COVID-19 rate was 39.3%; 31.7% required ICU, 24.6% mechanical ventilation, and 21.2% died. Machine learning algorithms and clinical judgment were used to improve model performance and clinical utility, resulting in the selection of eight predictors: age, sex, dyspnea, diabetes mellitus, troponin, C-reactive protein, D-dimer, and aspartate aminotransferase. The discriminative ability was excellent for both the severe COVID-19 (training area under the curve [AUC]=0.82, validation AUC=0.82) and mortality (training AUC= 0.85, validation AUC=0.81) models. These models were incorporated into a mobile-friendly website. This web-based risk prediction model can be used at the bedside for prediction of severe COVID-19 using data mostly available at the time of presentation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015143 Philadelphia City located in Pennsylvania.

Related Publications

Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
February 2022, Scientific reports,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
February 2021, Kidney360,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
July 2021, Epidemiology and infection,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
May 2025, BMC infectious diseases,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
March 2022, Journal of medical virology,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
January 2020, PloS one,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
October 2020, The Lancet. Digital health,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
December 2021, Mayo Clinic proceedings,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
February 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Sang H Woo, and Arturo J Rios-Diaz, and Alan A Kubey, and Dianna R Cheney-Peters, and Lily L Ackermann, and Divya M Chalikonda, and Chantel M Venkataraman, and Joshua M Riley, and Michael Baram
September 2025, BMC pulmonary medicine,
Copied contents to your clipboard!